stockportfolio.pro
Stocks / CLBT vs INFQ
CLBT vs INFQ
Cellebrite DI Ltd. and Infleqtion, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Technology.
| Cellebrite DI Ltd. (CLBT) | Infleqtion, Inc. (INFQ) | |
|---|---|---|
| Market cap | $3.2B | $3.0B |
| Revenue (latest FY) | $475.68M | $0 |
| Net income (latest FY) | $78.33M | $-66.93M |
| Revenue growth (5y CAGR) | 20.7% | — |
| Net margin | 16.5% | — |
| Return on equity | 16.2% | 32.1% |
| P/E ratio | 45.5 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 2 | 0 |
| Positive free cash flow | Yes | — |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open CLBT — free Open INFQ — freeFrequently asked questions
Which is bigger, CLBT or INFQ?
Cellebrite DI Ltd. is larger by market capitalization — $3.2B versus $3.0B.
Which grows faster, CLBT or INFQ?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.